Diagnostic Value and Cost-Effectiveness of Next-Generation Sequencing–Based Testing for Treatment of Patients with Advanced/Metastatic Non-Squamous Non–Small-Cell Lung Cancer in the United States
Denise Zou, Weicheng Ye, Lisa M. Hess, Naleen Raj Bhandari, Amine Ale-Ali, Jacinda Foster, Peter Quon, M. Harris
Topics & Concepts
MedicineLung cancerOncologyCost effectivenessSquamous cell cancerCancerInternal medicineIntensive care medicineRisk analysis (engineering)Lung Cancer Treatments and MutationsCancer Genomics and DiagnosticsLung Cancer Diagnosis and Treatment